2011
DOI: 10.1073/pnas.1010045108
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic cross-talk allows labeling of O-linked β- N -acetylglucosamine-modified proteins via the N -acetylgalactosamine salvage pathway

Abstract: Hundreds of mammalian nuclear and cytoplasmic proteins are reversibly glycosylated by O-linked β-N-acetylglucosamine (O-GlcNAc) to regulate their function, localization, and stability. Despite its broad functional significance, the dynamic and posttranslational nature of O-GlcNAc signaling makes it challenging to study using traditional molecular and cell biological techniques alone. Here, we report that metabolic cross-talk between the N-acetylgalactosamine salvage and O-GlcNAcylation pathways can be exploite… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

13
326
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 296 publications
(339 citation statements)
references
References 43 publications
13
326
0
Order By: Relevance
“…To this end, we used a proteomics approach based on metabolic incorporation of Ac 4 GalNAz, which is processed intracellularly to UDPGlcNAz for use as the donor nucleotide sugar of OGT (53). O-GlcNAz groups are subsequently labeled with a biotin phosphine reagent through Staudinger ligation (54).…”
Section: Metabolic Labeling Identifies O-glcnac Proteins From Human Tmentioning
confidence: 99%
“…To this end, we used a proteomics approach based on metabolic incorporation of Ac 4 GalNAz, which is processed intracellularly to UDPGlcNAz for use as the donor nucleotide sugar of OGT (53). O-GlcNAz groups are subsequently labeled with a biotin phosphine reagent through Staudinger ligation (54).…”
Section: Metabolic Labeling Identifies O-glcnac Proteins From Human Tmentioning
confidence: 99%
“…Although these established methods provided great advancements for the detection of O-GlcNAc-modified proteins, the weak nature of metabolic labeling with peracetylated azido-GlcNAc has led to the development of better technologies. Subsequent studies have shown that GalNAz can be converted to UDP-GalNAz and epimerized to UDP-GlcNAz by mammalian biosynthetic enzymes, which is then be added to cells by OGT (Boyce et al 2011). Proof-of-principle experiments highlighting this metabolic labeling demonstrated that numerous proteins are OGlcNAc-modified, laying a solid framework for future studies to visualize and characterize dynamic O-GlcNAc-mediated signaling events (Boyce et al 2011).…”
Section: Hek293t Cells Ion Trap Etd Ms/msmentioning
confidence: 99%
“…Another approach, originally developed by Bertozzi and coworkers, relies on the promiscuity of the hexosamine biosynthetic pathway (HBP) to metabolically deliver azides into O-GlcNAcmodified proteins (44)(45)(46)(47)(48). Cells can be treated with the fully protected azide-bearing monosaccharide Ac 4 GlcNAz or Ac 4 GalNAz.…”
mentioning
confidence: 99%